Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 422

Sort by

Sort Order Select

Journal Articles

Early flow cytometry-based MRD predicts relapse in intermediate-risk AML from low- and middle-income countries

Blood (2025) 146 (Supplement 1): 1739.

https://doi.org/10.1182/blood-2025-1739

Published: 2025

Journal Articles

Clinical characteristics and comutational landscape of CSF3R mutations in acute myeloid leukemia

Lara Wiechers, Rabea Mecklenbrauck, Razif Gabdoulline, Henri C. Hupe, Piroska Poll, Rabia Shahswar, Franziska Westendorf, Walter Fiedler, Arnold Ganser, Florian Heidel, Michael Heuser, Felicitas R Thol

Blood (2025) 146 (Supplement 1): 1718.

https://doi.org/10.1182/blood-2025-1718

Published: 2025

Journal Articles

Umbilical cord blood CD34+ hematopoietic stem cell-derived natural killer cells in Acute Myeloid Leukemia – a phase I clinical study

Blood (2025) 146 (Supplement 1): 1640.

https://doi.org/10.1182/blood-2025-1640

Published: 2025

Journal Articles

Monitoring of CNS involvement in AML using ultrahigh-sensitivity next-generation sequencing of cell-free DNA

Blood (2025) 146 (Supplement 1): 3515.

https://doi.org/10.1182/blood-2025-3515

Published: 2025

Journal Articles

Long-term HIV remission of a perinatally infected individual, following a hematopoietic cell transplantation from a CCR5Δ32 homozygous donor for multiple myeloma: The kyiv patient

Sybiryna Korenkova, Bogdan Medvedev, Arnold Ganser, Torsten Haferlach, Iryna Raus, Hans Kreipe, Isabel Sanchez-Ortega, Anna Sureda Balarí, Damiano Rondelli, Frank Maldarelli, Paul Rubinstein, Dietger Niederwieser

Blood (2025) 146 (Supplement 1): 7800.

https://doi.org/10.1182/blood-2025-7800

Published: 2025

Journal Articles

10 Year Follow-up of CALGB 10603/Ratify: Midostaurin Versus Placebo Plus Intensive Chemotherapy in Newly Diagnosed FLT3 Mutant Acute Myeloid Leukemia Patients Aged 18-60 Years

Blood (2024) 144 (Supplement 1): 218.

https://doi.org/10.1182/blood-2024-201058

Published: 2024

Journal Articles

The Differential Impact of Secondary-Type Mutations in a Multinational Cohort of 5311 Intensively Treated Acute Myeloid Leukemia Patients

Jan-Niklas Eckardt, Marius Bill, Konstanze Döhner, Christian Rausch, Klaus H Metzeler, Karsten Spiekermann, Sebastian Stasik, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. H. Brummendorf, Utz Krug, Bernhard Wörmann, Hermann Einsele, Wolfgang Hiddemann, Dennis Görlich, Maria Cristina Sauerland, Björn Steffen, Andreas Neubauer, Andreas Burchert, Kerstin Schaefer-Eckart, Wolfgang E. Berdel, Christoph Schliemann, Stefan W. Krause, Mathias Hänel, Maher Hanoun, Martin Kaufmann, Lars Fransecky, Jan Braess, Johannes Schetelig, Jan Moritz Middeke, Lars Bullinger, Michael Heuser, Felicitas R Thol, Hubert Serve, Claudia D Baldus, Uwe Platzbecker, Carsten Mueller-Tidow, Barbora Weinbergerova, Jiri Mayer, Pierre-Yves Dumas, Sarah Bertoli, Eric Delabesse, Christian Récher, Arnaud Pigneux, Tobias Herold, Arnold Ganser, Hartmut Döhner, Martin Bornhäuser, Christian Thiede, Christoph Röllig

Blood (2024) 144 (Supplement 1): 2934.

https://doi.org/10.1182/blood-2024-201945

Published: 2024

Journal Articles

Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia

Blood (2024) 144 (12): 1257–1270.

https://doi.org/10.1182/blood.2024023890

Published: 2024

Includes: Supplemental data

Journal Articles

Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation

Clara Philine Wienecke, Bennet Heida, Letizia Venturini, Razif Gabdoulline, Katja Krüger, Katrin Teich, Konstantin Büttner, Martin Wichmann, Wolfram Puppe, Blerina Neziri, Marlene Reuter, Elke Dammann, Michael Stadler, Arnold Ganser, Lothar Hambach, Felicitas Thol, Michael Heuser

Blood (2024) 144 (3): 296–307.

https://doi.org/10.1182/blood.2023022697

Published: 2024

Includes: Supplemental data

Journal Articles

How I treat refractory and relapsed acute myeloid leukemia

Felicitas Thol, Hartmut Döhner, Arnold Ganser

Blood (2024) 143 (1): 11–20.

https://doi.org/10.1182/blood.2023022481

Published: 2024

Journal Articles

Prognostic Impact of Clonality of Myelodysplasia-Related Gene Mutations in AML

Rabea Mecklenbrauck, Nora Borchert, Piroska Klement, Carolin Funke, Maximilian Brandes, Louisa-Kristin Dallmann, Walter Fiedler, Jürgen Krauter, Arne Trummer, Bernd Hertenstein, Verena I. Gaidzik, Konstanze Döhner, Hartmut Döhner, Arnold Ganser, Felicitas Thol, Michael Heuser

Blood (2023) 142 (Supplement 1): 817.

https://doi.org/10.1182/blood-2023-179412

Published: 2023

Journal Articles

The Genomic Landscape and Its Clinical Implication in NPM1 -Mutated AML Patients: A Study within the AMLSG 09-09 Clinical Trial

Blood (2023) 142 (Supplement 1): 4311.

https://doi.org/10.1182/blood-2023-185566

Published: 2023

Journal Articles

Help for Ukrainian Hematology Patients (HUP) - a Global Initiative Supporting the Establishment of Hematology Centers and Hematopoietic Cell Transplantation Programs in a Time of War

Blood (2023) 142 (Supplement 1): 264.

https://doi.org/10.1182/blood-2023-185883

Published: 2023

Journal Articles

Detection of Isolated Extramedullary AML Using Next-Generation Sequencing of Cell-Free DNA

Henri C. Hupe, Clara P. Wienecke, Stephan Bartels, Elisa Schipper, Jannika Leßmann, Alina Lasch, Maximilian Bader, Razif Gabdoulline, Martin Wichmann, Wolfram Puppe, Michael Stadler, Matthias Eder, Arnold Ganser, Felicitas Thol, Michael Heuser

Blood (2023) 142 (Supplement 1): 4330.

https://doi.org/10.1182/blood-2023-181522

Published: 2023

Journal Articles

Myelodysplasia-Related Gene Mutations for NGS-Based MRD Assessment in Acute Myeloid Leukemia

Maximilian Bader, Arba Mahmuti, Jannika Leßmann, Henri C Hupe, Razif Gabdoulline, Martin Wichmann, Letizia Venturini, Michael Stadler, Wolfram Puppe, Walter Fiedler, Jürgen Krauter, Arne Trummer, Bernd Hertenstein, Matthias Eder, Arnold Ganser, Felicitas Thol, Michael Heuser, Rabea Mecklenbrauck

Blood (2023) 142 (Supplement 1): 2944.

https://doi.org/10.1182/blood-2023-181637

Published: 2023

Journal Articles

Feasibility and Relevance of Incorporating Genetic Testing By Next-Generation Sequencing for Acute Myeloid Leukemia Patients Treated in Low- and Middle-Income Countries

Blood (2023) 142 (Supplement 1): 2929.

https://doi.org/10.1182/blood-2023-189806

Published: 2023

Journal Articles

Role of allotransplantation in older patients with AML

Arnold Ganser

Blood (2023) 141 (3): 217–218.

https://doi.org/10.1182/blood.2022018786

Published: 2023

Journal Articles

Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

Blood (2022) 140 (Supplement 1): 7585–7586.

https://doi.org/10.1182/blood-2022-156076

Published: 2022

Journal Articles

Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation

Blood (2022) 140 (Supplement 1): 2389–2391.

https://doi.org/10.1182/blood-2022-157890

Published: 2022

Journal Articles

Gemtuzumab Ozogamicin Plus Intensive Chemotherapy for Patients with NPM1 -Mutated Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 2010–2013.

https://doi.org/10.1182/blood-2022-166084

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Early flow cytometry-based MRD predicts relapse in intermediate-risk AML from low- and middle-income countries

Clinical characteristics and comutational landscape of CSF3R mutations in acute myeloid leukemia

Umbilical cord blood CD34+ hematopoietic stem cell-derived natural killer cells in Acute Myeloid Leukemia – a phase I clinical study

Monitoring of CNS involvement in AML using ultrahigh-sensitivity next-generation sequencing of cell-free DNA

Long-term HIV remission of a perinatally infected individual, following a hematopoietic cell transplantation from a CCR5Δ32 homozygous donor for multiple myeloma: The kyiv patient

10 Year Follow-up of CALGB 10603/Ratify: Midostaurin Versus Placebo Plus Intensive Chemotherapy in Newly Diagnosed FLT3 Mutant Acute Myeloid Leukemia Patients Aged 18-60 Years

The Differential Impact of Secondary-Type Mutations in a Multinational Cohort of 5311 Intensively Treated Acute Myeloid Leukemia Patients

Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia

Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation

How I treat refractory and relapsed acute myeloid leukemia

Prognostic Impact of Clonality of Myelodysplasia-Related Gene Mutations in AML

The Genomic Landscape and Its Clinical Implication in NPM1 -Mutated AML Patients: A Study within the AMLSG 09-09 Clinical Trial

Help for Ukrainian Hematology Patients (HUP) - a Global Initiative Supporting the Establishment of Hematology Centers and Hematopoietic Cell Transplantation Programs in a Time of War

Detection of Isolated Extramedullary AML Using Next-Generation Sequencing of Cell-Free DNA

Myelodysplasia-Related Gene Mutations for NGS-Based MRD Assessment in Acute Myeloid Leukemia

Feasibility and Relevance of Incorporating Genetic Testing By Next-Generation Sequencing for Acute Myeloid Leukemia Patients Treated in Low- and Middle-Income Countries

Role of allotransplantation in older patients with AML

Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation

Gemtuzumab Ozogamicin Plus Intensive Chemotherapy for Patients with NPM1 -Mutated Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only